Highlight HEALTH Web Directory » Drug Information » Cancer Therapy Subscribe to this category  


Sort by: PageRank | Hits | Alphabetical
Regular Links

PR: 5

Arimidex (anastrozole)
Arimidex is an aromatase inhibitor with over 8 years of clinical data and is approved for adjuvant therapy (following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.
Date added: 24/10/09 | http://www.arimidex.com/

N/A

Faslodex (fulvestrant)
Faslodex (fulvestrant) is a hormonal treatment for metastatic hormone receptor-positive breast cancer. It is for postmenopausal women whose disease has returned or progressed following an antiestrogen (medication that blocks estrogen), such as tamoxifen.
Date added: 16/12/09 | http://www.faslodex.com/

Total records: 2
    » Recent Highlight HEALTH articles
    • New Approach to Immune Cell Analysis Seen as First Step to Better Distinguish Health and Disease

      Tuesday, March 09th, 2010

      Investigators have developed a new mathematical approach to analyze molecular data derived from complex mixtures of immune cells. This approach, when combined with well-established techniques, readily identifies changes in small samples of human whole blood, and has the potential to distinguish betw

    • Scientists Find New Form of Prion Disease that Damages Brain Arteries

      Tuesday, March 09th, 2010

      National Institutes of Health (NIH) scientists investigating how prion diseases destroy the brain have observed a new form of the disease in mice that does not cause the sponge-like brain deterioration typically seen in prion diseases. Instead, it resembles a form of human Alzheimer's disease, cereb

    • Food Allergy-Related Disorder Linked to Master Allergy Gene

      Monday, March 08th, 2010

      Scientists have identified a region of a human chromosome that is associated with eosinophilic esophagitis (EoE), a recently recognized allergic disease. People with EoE frequently have difficulty eating or may be allergic to one or more foods. This study further suggests that a suspected so-called

    • The National Health Observances Toolkit

      Wednesday, March 03rd, 2010

      To help promote certain health observances, the National Health Observances Toolkit provides information and ideas to engage the public in health promotion activities.

    • Childhood Asthma Treatment: Not One-Size-Fits-All

      Tuesday, March 02nd, 2010

      A new study has found the addition of long-acting beta-agonist therapy to be the most effective of three step-up, or supplemental, treatments for children whose asthma is not well controlled on low doses of inhaled corticosteroids alone. The study was designed to provide needed evidence for selectin

    • NHGRI Launches Online Genomics Center for Educators of Nurses, Physician Assistants

      Friday, February 26th, 2010

      An online tool to help educators teach the next generation of nurses and physician assistants about genetics and genomics was launched today by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health. The tool is part of NHGRI's effort to address the growing n

    • Emerging Science, Tech Advances Highlight New NIH Common Fund Programs

      Thursday, February 25th, 2010

      Programs to create a new center for the study of stem cells and to increase capacity to deal with global health issues were among seven scientific initiatives announced today by NIH Director Francis S. Collins, M.D., Ph.D. The seven research programs are supported through the NIH Common Fund, which

advertisement